Condition
Metabolic Cardiomyopathy
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07081711Not Yet Recruiting
Longitudinal Validation of CIRC Technologies
NCT05654272Recruiting
Development of CIRC Technologies
NCT06794710Not ApplicableNot Yet Recruiting
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
NCT04009642Completed
Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
Showing all 4 trials